TPIRC, Translational Pulmonary and Immunology Research Center, was established in 2015 by Dr. Inderpal Randhawa. Early in his career, Dr. Randhawa dedicated his career to challenging conventional approaches to treating life-threatening food allergies, and now multiple rare diseases. This challenge involved meticulously studying vast amounts of genetic and environmental data to develop personalized, data-driven treatment plans for each patient. This
multi-system approach yielded an unprecedented success rate, allowing countless food-allergic individuals, particularly children and young adults, to safely enjoy foods that were once considered dangerous.
TPIRC’s success wasn’t limited to food allergies. Dr. Randhawa’s innovative model, built on precision medicine and data analysis, proved effective in tackling a wider range of complex and often rare diseases. This unique approach led TPIRC to become a safe and trustful clinic and research center for patients facing the challenges of rare and orphan diseases.
Our mission is two-fold: to advance treatment discovery at a pace that helps our patients today while building a scalable model of success to accelerate the rate of research discovery for all diseases.
To harness the power of big data to unravel the mysteries of rare diseases and deliver cures that restore hope and health to patients and families around the world.
With a clear mission and vision in mind, TPIRC focuses on the development of cutting-edge, individualized treatment protocols for rare and orphan diseases utilizing comprehensive diagnostic tools and patient-driven research.